1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 22

2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
2.2 RESEARCH DESIGN 23
2.3 SECONDARY DATA 24
2.3.1 SECONDARY SOURCES 24
2.4 PRIMARY DATA 24
2.4.1 KEY DATA FROM PRIMARY SOURCES 25
2.5 MARKET SIZE ESTIMATION 26
2.5.1 BOTTOM-UP APPROACH 26
2.5.2 TOP-DOWN APPROACH 27
2.5.3 GROWTH FORECAST 27
2.6 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.7 ASSUMPTIONS FOR THE STUDY 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 33
4.1 BLOOD SCREENING MARKET OVERVIEW 33
4.2 ASIA PACIFIC: BLOOD SCREENING MARKET SHARE, BY END USER & COUNTRY (2018) 34
4.3 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD BILLION) 35
4.4 GEOGRAPHICAL SNAPSHOT OF THE BLOOD SCREENING MARKET 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Increasing demand for donated blood and rising number of blood donations 37
5.2.1.2 Rising prevalence of infectious diseases and emergence of newer pathogens 38
5.2.2 OPPORTUNITIES 39
5.2.2.1 Technological advancements 39
5.2.2.2 Emerging economies 39
5.2.3 CHALLENGES 40
5.2.3.1 Need for reducing blood screening prices 40

6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE 41
6.1 INTRODUCTION 42
6.2 REAGENTS & KITS 43
6.2.1 NAT REAGENTS & KITS 43
6.2.1.1 High sensitivity and rising use of NAT are boosting demand for related reagents and kits 43
6.2.1.2 Enzymes & polymerases 44
6.2.1.3 Standards & controls 44
6.2.1.4 Probes & primers 44
6.2.1.5 Buffers, nucleotides, & solutions 45
6.2.1.6 Labeling & detection reagents 45
6.2.2 ELISA REAGENTS & KITS 45
6.2.2.1 Ease of use and cost-effectiveness of ELISA reagents & kits will drive market growth 45
6.2.2.2 Immunosorbents 46
6.2.2.3 Controls 46
6.2.2.4 Conjugates 46
6.2.2.5 Substrates 46
6.2.2.6 Sample diluents & wash solutions 46
6.2.3 OTHER REAGENTS & KITS 47
6.2.3.1 Increasing use of western blot tests and rapid tests will drive the growth of this market segment 47
6.3 INSTRUMENTS 47
6.3.1 RENTAL PURCHASE 48
6.3.1.1 Convenience and cost-effectiveness of renting instruments has resulted in greater end-user preference 48
6.3.2 OUTRIGHT PURCHASE 49
6.3.2.1 Availability of government support will increase the outright purchase of instruments 49
6.4 SOFTWARE & SERVICES 50
6.4.1 INCREASING ADOPTION OF INSTRUMENTS WILL DRIVE THE DEMAND FOR RELATED SOFTWARE AND SERVICES 50

7 BLOOD SCREENING MARKET, BY TECHNOLOGY 51
7.1 INTRODUCTION 52
7.2 NUCLEIC ACID TESTING 53
7.2.1 TRANSCRIPTION-MEDIATED AMPLIFICATION 54
7.2.1.1 High sensitivity of these assays to support market growth 54
7.2.2 REAL-TIME POLYMERASE CHAIN REACTION 55
7.2.2.1 Real-time PCR procedures provide more accurate and effective results as compared to conventional PCR 55
7.3 ENZYME-LINKED IMMUNOSORBENT ASSAY 56
7.3.1 CHEMILUMINESCENCE IMMUNOASSAY 57
7.3.1.1 CLIA is ultrasensitive, automated, and a good alternative to conventional methodologies 57
7.3.2 FLUORESCENT IMMUNOASSAY 58
7.3.2.1 Rising demand for safer and stable reagents and the development of novel markers to support the growth of this market segment 58
7.3.3 COLORIMETRIC IMMUNOASSAYS 59
7.3.3.1 CI offers low sensitivity as it uses vulnerable/limited signal amplification strategies 59
7.4 RAPID TESTS 60
7.4.1 RISING AWARENESS ABOUT RAPID TESTS IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH 60
7.5 WESTERN BLOT ASSAY 60
7.5.1 GROWING PREVALENCE OF TTIS IN DEVELOPING COUNTRIES HAS RESULTED IN THE INCREASED DEMAND FOR WESTERN BLOT ASSAYS 60
7.6 NEXT-GENERATION SEQUENCING 61
7.6.1 NGS IS AN EMERGING TECHNOLOGY IN THE BLOOD SCREENING MARKET 61

8 BLOOD SCREENING MARKET, BY END USER 62
8.1 INTRODUCTION 63
8.2 BLOOD BANKS 64
8.2.1 BLOOD BANKS HOLD THE LARGEST SHARE OF THE BLOOD SCREENING MARKET 64
8.3 HOSPITALS 64
8.3.1 INCREASING NUMBER OF SURGICAL PROCEDURES WILL DRIVE THE GROWTH OF THE HOSPITALS SEGMENT 64

9 BLOOD SCREENING MARKET, BY REGION 66
9.1 INTRODUCTION 67
9.2 NORTH AMERICA 67
9.2.1 US 70
9.2.1.1 The US dominates the global blood screening market 70
9.2.2 CANADA 73
9.2.2.1 Growing volume of surgical procedures performed and high burden of cancer to support market growth 73
9.3 EUROPE 75
9.3.1 GERMANY 78
9.3.1.1 Germany is the largest market for blood screening technologies in Europe 78
9.3.2 FRANCE 80
9.3.2.1 Increasing prevalence of HIV to support market growth 80
9.3.3 UK 82
9.3.3.1 Government support to prevent transmission of HIV and other infections will drive market growth 82
9.3.4 ITALY 84
9.3.4.1 Italy is witnessing an increase in the number of blood donors 84
9.3.5 SPAIN 86
9.3.5.1 Increasing adoption of NAT technology will support market growth 86
9.3.6 REST OF EUROPE 88
9.4 ASIA PACIFIC 90
9.4.1 CHINA 94
9.4.1.1 China has a high prevalence of infectious diseases 94
9.4.2 JAPAN 96
9.4.2.1 Japan has witnessed an increase in the adoption of advanced blood screening technologies 96
9.4.3 INDIA 98
9.4.3.1 Increasing number of road accidents will support market growth 98
9.4.4 AUSTRALIA 100
9.4.4.1 Rising number of blood donations will propel market growth 100
9.4.5 REST OF ASIA PACIFIC 102
9.5 LATIN AMERICA 104
9.5.1 BRAZIL 106
9.5.1.1 Increasing incidence of cancer will support the growth of this market 106
9.5.2 REST OF LATIN AMERICA 109
9.6 MIDDLE EAST & AFRICA 111
9.6.1 RISING PREVALENCE OF INFECTIOUS DISEASES WILL DRIVE MARKET GROWTH IN THE REGION 111

10 COMPETITIVE LANDSCAPE 114
10.1 OVERVIEW 114
10.2 MARKET SHARE ANALYSIS, 2018 116
10.2.1 MARKET SHARE ANALYSIS FOR NAT BLOOD SCREENING, 2018 116
10.2.2 MARKET SHARE ANALYSIS FOR TOTAL BLOOD SCREENING, 2018 117
10.3 COMPETITIVE SCENARIO 118
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019) 118
10.3.2 PRODUCT LAUNCHES (2017–2019) 119
10.3.3 EXPANSIONS (2017–2019) 119
10.3.4 ACQUISITIONS (2017–2019) 119
10.4 COMPETITIVE LEADERSHIP MAPPING (2019) 120
10.4.1 VENDOR INCLUSION CRITERIA 120
10.4.2 VISIONARY LEADERS 120
10.4.3 INNOVATORS 120
10.4.4 DYNAMIC DIFFERENTIATORS 120
10.4.5 EMERGING COMPANIES 120

11 COMPANY PROFILES 122
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 GRIFOLS 122
11.2 F. HOFFMANN-LA ROCHE 125
11.3 ABBOTT LABORATORIES 128
11.4 BIOMÉRIEUX 131
11.5 BIO-RAD LABORATORIES 133
11.6 BECTON, DICKSON AND COMPANY 136
11.7 DANAHER CORPORATION 138
11.8 ORTHO CLINICAL DIAGNOSTICS 140
11.9 SIEMENS HEALTHINEERS 141
11.10 THERMO FISHER SCIENTIFIC 143
11.11 DIASORIN 145
11.12 GE HEALTHCARE 148
11.13 MERCK KGAA 150
11.14 PERKINELMER 152
11.15 BIO-TECHNE 154
11.16 GFE 156
11.17 TRINITY BIOTECH 157
11.18 J. MITRA DIAGNOSTICS PVT. LTD. 158
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 159
12.1 DISCUSSION GUIDE 159
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 163
12.3 AVAILABLE CUSTOMIZATIONS 165
12.4 RELATED REPORTS 165
12.5 AUTHOR DETAILS 166

LIST OF TABLES
TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 37
TABLE 2 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 42
TABLE 3 BLOOD SCREENING REAGENTS & KITS MARKET, BY REGION, 2017–2024 (USD MILLION) 43
TABLE 4 BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 43
TABLE 5 NAT REAGENTS & KITS MARKET, BY REGION, 2017–2024 (USD MILLION) 44
TABLE 6 NAT REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 44
TABLE 7 ELISA REAGENTS & KITS MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 8 ELISA REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 46
TABLE 9 OTHER REAGENTS & KITS MARKET, BY REGION, 2017–2024 (USD MILLION) 47
TABLE 10 BLOOD SCREENING INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 48
TABLE 11 BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 48
TABLE 12 MARKET FOR RENTAL PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2017–2024 (USD MILLION) 49
TABLE 13 MARKET FOR OUTRIGHT PURCHASE OF BLOOD SCREENING INSTRUMENTS, BY REGION, 2017–2024 (USD MILLION) 49
TABLE 14 BLOOD SCREENING SOFTWARE & SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 15 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 52
TABLE 16 BLOOD SCREENING MARKET FOR NAT, BY REGION, 2017–2024 (USD MILLION) 53
TABLE 17 BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 54
TABLE 18 TRANSCRIPTION-MEDIATED AMPLIFICATION MARKET, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 19 REAL-TIME PCR MARKET, BY REGION, 2017–2024 (USD MILLION) 55
TABLE 20 BLOOD SCREENING MARKET FOR ELISA, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 21 BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 57
TABLE 22 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 58
TABLE 23 FLUORESCENT IMMUNOASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 24 COLORIMETRIC IMMUNOASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 25 BLOOD SCREENING MARKET FOR RAPID TESTS, BY REGION, 2017–2024 (USD MILLION) 60
TABLE 26 BLOOD SCREENING MARKET FOR WESTERN BLOT ASSAYS, BY REGION, 2017–2024 (USD MILLION) 61
TABLE 27 BLOOD SCREENING MARKET FOR NGS, BY REGION, 2017–2024 (USD MILLION) 61
TABLE 28 BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 63
TABLE 29 BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2017–2024 (USD MILLION) 64
TABLE 30 BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2017–2024 (USD MILLION) 65
TABLE 31 BLOOD SCREENING MARKET, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 32 NORTH AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 33 NORTH AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 69
TABLE 34 NORTH AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 69
TABLE 35 NORTH AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 69
TABLE 36 NORTH AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 69
TABLE 37 NORTH AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 70
TABLE 38 NORTH AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 70
TABLE 39 NORTH AMERICA: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 70
TABLE 40 INCIDENCE OF VARIOUS CANCERS IN THE US, 2018 VS. 2025 71
TABLE 41 US: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 71
TABLE 42 US: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 71
TABLE 43 US: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 71
TABLE 44 US: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 72
TABLE 45 US: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 72
TABLE 46 US: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 72
TABLE 47 US: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 72
TABLE 48 CANADA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 73
TABLE 49 CANADA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 74
TABLE 50 CANADA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 74
TABLE 51 CANADA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 74
TABLE 52 CANADA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 74
TABLE 53 CANADA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 75
TABLE 54 CANADA: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 75
TABLE 55 EUROPE: BLOOD SCREENING MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 76
TABLE 56 EUROPE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 76
TABLE 57 EUROPE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 76
TABLE 58 EUROPE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 77
TABLE 59 EUROPE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 77
TABLE 60 EUROPE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 77
TABLE 61 EUROPE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 77
TABLE 62 EUROPE: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 78
TABLE 63 GERMANY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 78
TABLE 64 GERMANY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 78
TABLE 65 GERMANY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 79
TABLE 66 GERMANY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 79
TABLE 67 GERMANY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 79
TABLE 68 GERMANY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 79
TABLE 69 GERMANY: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 80
TABLE 70 FRANCE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 80
TABLE 71 FRANCE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 80
TABLE 72 FRANCE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 81
TABLE 73 FRANCE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 81
TABLE 74 FRANCE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 81
TABLE 75 FRANCE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 81
TABLE 76 FRANCE: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 82
TABLE 77 UK: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 82
TABLE 78 UK: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 83
TABLE 79 UK: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 83
TABLE 80 UK: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 83
TABLE 81 UK: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 83
TABLE 82 UK: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 84
TABLE 83 UK: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 84
TABLE 84 ITALY: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 84
TABLE 85 ITALY: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 85
TABLE 86 ITALY: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 85
TABLE 87 ITALY: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 85
TABLE 88 ITALY: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 85
TABLE 89 ITALY: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 86
TABLE 90 ITALY: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 86
TABLE 91 SPAIN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 86
TABLE 92 SPAIN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 87
TABLE 93 SPAIN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 87
TABLE 94 SPAIN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 87
TABLE 95 SPAIN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 87
TABLE 96 SPAIN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 88
TABLE 97 SPAIN: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 88
TABLE 98 ROE: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 88
TABLE 99 ROE: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 100 ROE: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 89
TABLE 101 ROE: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 89
TABLE 102 ROE: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 103 ROE: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 90
TABLE 104 ROE: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 90
TABLE 105 ASIA PACIFIC: BLOOD SCREENING MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 92
TABLE 106 ASIA PACIFIC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 92
TABLE 107 ASIA PACIFIC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 92
TABLE 108 ASIA PACIFIC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 93
TABLE 109 ASIA PACIFIC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 93
TABLE 110 ASIA PACIFIC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 93
TABLE 111 ASIA PACIFIC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 93
TABLE 112 ASIA PACIFIC: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 94
TABLE 113 CHINA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 94
TABLE 114 CHINA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 94
TABLE 115 CHINA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 95
TABLE 116 CHINA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 95
TABLE 117 CHINA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 95
TABLE 118 CHINA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 95
TABLE 119 CHINA: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 96
TABLE 120 JAPAN: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 96
TABLE 121 JAPAN: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 96
TABLE 122 JAPAN: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 97
TABLE 123 JAPAN: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 97
TABLE 124 JAPAN: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 97
TABLE 125 JAPAN: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 97
TABLE 126 JAPAN: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 98
TABLE 127 INDIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 98
TABLE 128 INDIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 99
TABLE 129 INDIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 99
TABLE 130 INDIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 99
TABLE 131 INDIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 99
TABLE 132 INDIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 100
TABLE 133 INDIA: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 100
TABLE 134 AUSTRALIA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 100
TABLE 135 AUSTRALIA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 101
TABLE 136 AUSTRALIA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 101
TABLE 137 AUSTRALIA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 101
TABLE 138 AUSTRALIA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 101
TABLE 139 AUSTRALIA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 102
TABLE 140 AUSTRALIA: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 102
TABLE 141 ROAPAC: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 102
TABLE 142 ROAPAC: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 103
TABLE 143 ROAPAC: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 103
TABLE 144 ROAPAC: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 103
TABLE 145 ROAPAC: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 103
TABLE 146 ROAPAC: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 104
TABLE 147 ROAPAC: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 104
TABLE 148 LATIN AMERICA: BLOOD SCREENING MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 104
TABLE 149 LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 105
TABLE 150 LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 105
TABLE 151 LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 105
TABLE 152 LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 105
TABLE 153 LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 106
TABLE 154 LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 106
TABLE 155 LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 106
TABLE 156 INCIDENCE OF VARIOUS CANCERS IN BRAZIL, 2018 VS. 2025 107
TABLE 157 BRAZIL: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 107
TABLE 158 BRAZIL: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 107
TABLE 159 BRAZIL: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 107
TABLE 160 BRAZIL: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 108
TABLE 161 BRAZIL: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 108
TABLE 162 BRAZIL: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 108
TABLE 163 BRAZIL: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 108
TABLE 164 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 109
TABLE 165 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 109
TABLE 166 REST OF LATIN AMERICA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 109
TABLE 167 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 110
TABLE 168 REST OF LATIN AMERICA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 169 REST OF LATIN AMERICA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 110
TABLE 170 REST OF LATIN AMERICA: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 110
TABLE 171 MEA: BLOOD SCREENING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 111
TABLE 172 MEA: BLOOD SCREENING MARKET FOR NAT, BY TYPE, 2017–2024 (USD MILLION) 111
TABLE 173 MEA: BLOOD SCREENING MARKET FOR ELISA, BY PLATFORM, 2017–2024 (USD MILLION) 112
TABLE 174 MEA: BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 112
TABLE 175 MEA: BLOOD SCREENING REAGENTS & KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 112
TABLE 176 MEA: BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, 2017–2024 (USD MILLION) 112
TABLE 177 MEA: BLOOD SCREENING MARKET, BY END USER, 2017–2024 (USD MILLION) 113

LIST OF FIGURES
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 25
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 26
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 27
FIGURE 4 DATA TRIANGULATION METHODOLOGY 28
FIGURE 5 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD BILLION) 30
FIGURE 6 BLOOD SCREENING MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD BILLION) 31
FIGURE 7 BLOOD SCREENING MARKET, BY END USER, 2019 VS. 2024 (USD BILLION) 31
FIGURE 8 GEOGRAPHIC OUTLOOK: BLOOD SCREENING MARKET 32
FIGURE 9 INCREASING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO DRIVE MARKET GROWTH 33
FIGURE 10 BLOOD BANKS WERE THE LARGEST END USERS OF BLOOD SCREENING PRODUCTS AND SERVICES IN THE ASIA PACIFIC IN 2018 34
FIGURE 11 REAGENTS & KITS SEGMENT DOMINATES THE BLOOD SCREENING MARKET 35
FIGURE 12 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 35
FIGURE 13 RISE IN HIV-AFFECTED PATIENT POPULATION, 2000–2018 38
FIGURE 14 REAGENTS & KITS SEGMENT IS EXPECTED TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD 42
FIGURE 15 NAT SEGMENT WILL CONTINUE TO DOMINATE THE BLOOD SCREENING MARKET IN 2024 52
FIGURE 16 BLOOD BANKS SEGMENT WILL CONTINUE TO DOMINATE THE BLOOD SCREENING MARKET DURING THE FORECAST PERIOD 63
FIGURE 17 NORTH AMERICA: BLOOD SCREENING MARKET SNAPSHOT 68
FIGURE 18 ASIA PACIFIC: BLOOD SCREENING MARKET SNAPSHOT 91
FIGURE 19 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2019 114
FIGURE 20 MARKET EVOLUTION FRAMEWORK 115
FIGURE 21 NAT BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 116
FIGURE 22 BLOOD SCREENING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 117
FIGURE 23 COMPETITIVE LEADERSHIP MAPPING 121
FIGURE 24 GRIFOLS: COMPANY SNAPSHOT (2018) 122
FIGURE 25 F. HOFFMAN-LA ROCHE: COMPANY SNAPSHOT (2018) 125
FIGURE 26 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018) 128
FIGURE 27 BIOMÉRIEUX: COMPANY SNAPSHOT (2018) 131
FIGURE 28 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2018) 133
FIGURE 29 BECTON, DICKSON AND COMPANY: COMPANY SNAPSHOT (2018) 136
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2018) 138
FIGURE 31 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2018) 141
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018) 143
FIGURE 33 DIASORIN: COMPANY SNAPSHOT (2018) 145
FIGURE 34 GENERAL ELECTRIC: COMPANY SNAPSHOT (2018) 148
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2018) 150
FIGURE 36 PERKINELMER: COMPANY SNAPSHOT (2018) 152
FIGURE 37 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2018) 154